Human Rantes ELISA

RANTES is a chemotactic protein for T cells, eosinophils, and basophils. RANTES is produced by circulating T-cells. The synthesis of RANTES is induced by TNF-alpha and IL1-alpha. It plays an active role in recruiting leukocytes into inflammatory sites. With the help of particular cytokines that are released by T cells, Rantes also induces the proliferation and activation of certain natural-killer (NK) cells to form CC-Chemokine-activated killer cells. It is also an HIV-suppressive factor released from CD8+ T cells. RANTES increases the adherence of monocytes to endothelial cells.

A. Benefits:

  • Cost-effective analysis - High Quality with the most competitive price.

  • Efficient and flexible - Multiple samples can be analyzed simultaneously with a flexible number of assay wells.

  • Specific- A pair of highly selective antibodies specifically against human Rantes.

  • Simple procedure All in one system with a pre-coated 96-well plate.

B. Principle of the technology

Rantes ELISA is based on the principle of a solid phase enzyme-linked immunosorbent assay. The assay utilizes rabbit anti-human Rantes for immobilization on the microtiter wells and biotinated rabbit anti-human Rantes antibodies along with streptavidin conjugated to horseradish peroxidase (HRP) for detection. The test sample is allowed to react simultaneously with the two antibodies, resulting in the Rantes molecules being sandwiched between the solid phase and enzyme-linked antibodies. After incubation, the wells are washed to remove unbound-labeled antibodies. A HRP substrate, TMB, is added to result in the development of a blue color. The color development is then stopped with the addition of Stop Solution changing the color to yellow. The concentration of Rantes is directly proportional to the color intensity of the test sample. Absorbance is measured spectrophotometrically at 450 nm.

Figure 1
Diagram

Figure 2
Figure 2

 

 Product Size Cat. Price
Human Rantes ELISA 96 EA-0506 $319
  • Human Rantes ELISA User Manual (PDF)
Related information:
©2007-2008 Signosis, Inc.